Cargando…

T-Helper Cytokine Profiles in Patients with Kawasaki Disease

BACKGROUND AND OBJECTIVES: Kawasaki disease is an acute systemic vasculitis of which pathogenesis suspected is caused by immune dysregulation. The goal of this study is to evaluate the activation pattern of T helper cell type 1 (Th1) and T helper cell type 2 (Th2) in patients with Kawasaki disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang Bum, Kim, Young Hyun, Hyun, Myung Chul, Kim, Yeo Hyang, Kim, Hee Sun, Lee, Young Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661368/
https://www.ncbi.nlm.nih.gov/pubmed/26617655
http://dx.doi.org/10.4070/kcj.2015.45.6.516
_version_ 1782402968488771584
author Lee, Sang Bum
Kim, Young Hyun
Hyun, Myung Chul
Kim, Yeo Hyang
Kim, Hee Sun
Lee, Young Hwan
author_facet Lee, Sang Bum
Kim, Young Hyun
Hyun, Myung Chul
Kim, Yeo Hyang
Kim, Hee Sun
Lee, Young Hwan
author_sort Lee, Sang Bum
collection PubMed
description BACKGROUND AND OBJECTIVES: Kawasaki disease is an acute systemic vasculitis of which pathogenesis suspected is caused by immune dysregulation. The goal of this study is to evaluate the activation pattern of T helper cell type 1 (Th1) and T helper cell type 2 (Th2) in patients with Kawasaki disease. SUBJECTS AND METHODS: Prospective study of 60 patients (male 36, female 24) with diagnosis of Kawasaki disease were enrolled. One hundred and eighty blood samples from these patients were collected according to the different clinical stages {before initial intravenous immunoglobulin (IVIG), 5 days after initial IVIG, 2 months after initial IVIG}. The plasma level of Th1 cytokines; interferon-gamma (IFN-γ) & interleukin (IL)-2 and Th2 cytokines; IL-4 & IL-10 were measured by enzyme-liked immunosorbent assay. RESULTS: In all patients, the plasma level of Th1 cytokines (IFN-γ, IL-2) and Th2 cytokines (IL-4 and IL-10) were markedly elevated during the acute stage of Kawasaki disease. Since then, the plasma level of all these cytokines decreased significantly along with the process of clinical stages. Regardless of the existence of coronary artery lesion or no response to initial IVIG treatment, there were no significant differences between them. CONCLUSION: These data suggest that both Th1 and Th2 cells may be activated simultaneously during the acute stage of Kawasaki disease. Further studies are therefore required to establish the difference of activation pattern of T helper cells between Kawasaki disease and other inflammatory diseases.
format Online
Article
Text
id pubmed-4661368
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The Korean Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-46613682015-11-29 T-Helper Cytokine Profiles in Patients with Kawasaki Disease Lee, Sang Bum Kim, Young Hyun Hyun, Myung Chul Kim, Yeo Hyang Kim, Hee Sun Lee, Young Hwan Korean Circ J Original Article BACKGROUND AND OBJECTIVES: Kawasaki disease is an acute systemic vasculitis of which pathogenesis suspected is caused by immune dysregulation. The goal of this study is to evaluate the activation pattern of T helper cell type 1 (Th1) and T helper cell type 2 (Th2) in patients with Kawasaki disease. SUBJECTS AND METHODS: Prospective study of 60 patients (male 36, female 24) with diagnosis of Kawasaki disease were enrolled. One hundred and eighty blood samples from these patients were collected according to the different clinical stages {before initial intravenous immunoglobulin (IVIG), 5 days after initial IVIG, 2 months after initial IVIG}. The plasma level of Th1 cytokines; interferon-gamma (IFN-γ) & interleukin (IL)-2 and Th2 cytokines; IL-4 & IL-10 were measured by enzyme-liked immunosorbent assay. RESULTS: In all patients, the plasma level of Th1 cytokines (IFN-γ, IL-2) and Th2 cytokines (IL-4 and IL-10) were markedly elevated during the acute stage of Kawasaki disease. Since then, the plasma level of all these cytokines decreased significantly along with the process of clinical stages. Regardless of the existence of coronary artery lesion or no response to initial IVIG treatment, there were no significant differences between them. CONCLUSION: These data suggest that both Th1 and Th2 cells may be activated simultaneously during the acute stage of Kawasaki disease. Further studies are therefore required to establish the difference of activation pattern of T helper cells between Kawasaki disease and other inflammatory diseases. The Korean Society of Cardiology 2015-11 2015-11-25 /pmc/articles/PMC4661368/ /pubmed/26617655 http://dx.doi.org/10.4070/kcj.2015.45.6.516 Text en Copyright © 2015 The Korean Society of Cardiology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Sang Bum
Kim, Young Hyun
Hyun, Myung Chul
Kim, Yeo Hyang
Kim, Hee Sun
Lee, Young Hwan
T-Helper Cytokine Profiles in Patients with Kawasaki Disease
title T-Helper Cytokine Profiles in Patients with Kawasaki Disease
title_full T-Helper Cytokine Profiles in Patients with Kawasaki Disease
title_fullStr T-Helper Cytokine Profiles in Patients with Kawasaki Disease
title_full_unstemmed T-Helper Cytokine Profiles in Patients with Kawasaki Disease
title_short T-Helper Cytokine Profiles in Patients with Kawasaki Disease
title_sort t-helper cytokine profiles in patients with kawasaki disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661368/
https://www.ncbi.nlm.nih.gov/pubmed/26617655
http://dx.doi.org/10.4070/kcj.2015.45.6.516
work_keys_str_mv AT leesangbum thelpercytokineprofilesinpatientswithkawasakidisease
AT kimyounghyun thelpercytokineprofilesinpatientswithkawasakidisease
AT hyunmyungchul thelpercytokineprofilesinpatientswithkawasakidisease
AT kimyeohyang thelpercytokineprofilesinpatientswithkawasakidisease
AT kimheesun thelpercytokineprofilesinpatientswithkawasakidisease
AT leeyounghwan thelpercytokineprofilesinpatientswithkawasakidisease